Cancer Biology and the Nuclear Envelope: Recent Advances May Elucidate Past Paradoxes (Advances in Experimental Medicine and Biology, 773). Dieser Artikel ist nicht verfügbar.
Sprache: Englisch
Verlag: Springer, 2014
Serie: Buch 160 von 544 - Advances in Experimental Medicine and Biology
- Hardcover
- Neu

Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes KönigreichRia Christie Collections
Verkäufer:in bei ZVAB seit 25. März 2015
Zustand: Neu
EUR 256,34
Artikelbeschreibung des Verkäufers
In English.
Bestandsnummer des Verkäufers ria9781489980311_new
- Titel
- Cancer Biology and the Nuclear Envelope: Recent Advances May Elucidate Past Paradoxes (Advances in Experimental Medicine and Biology, 773)
- Verlag
- Springer
- Erscheinungsjahr
- 2014
- Zustand
- New
- Einband
- Hardcover
- Sprache
- Englisch
- ISBN-10
- 1489980318
- ISBN-13
- 9781489980311
- Artikelgewicht
- 1.170 Gramm
- Serie
- Buch 160 von 544: Advances in Experimental Medicine and Biology
"Nuclear envelope (NE) defects have been linked to cancer biology since the mid-1800s, but it was not until the last few years that we have begun to understand these historical links and to realize that there are myriad ways that the NE impacts on tumorigenesis. The NE is a complex double membrane system that encloses the genome while providing structural support through the intermediate filament lamin polymer and regulating protein/ mRNA trafficking and signaling between the nucleus and cytoplasm via the nuclear pore complexes (NPCs). These functions already provide some mechanisms for NE influences on cancer biology but work in the past few years has elucidated many others. Lamins and many recently identified NE transmembrane proteins (NETs) have been now shown to function in DNA repair, regulation of cell cycle and signaling, apoptosis, cell migration in metastasis and nuclear architecture and morphology. This volume presents a comprehensive overview of the wide range of functions recently identified for NE proteins and their relevance in cancer biology, providing molecular mechanisms and evidence of their value as prognostic and diagnostic markers and suggesting new avenues for the treatment of cancer. Indeed some of these recent links are already yielding promising therapies, such as the current clinical trial of selective inhibitors of the nuclear export factor exportin in certain types of leukemia, melanoma and kidney cancer."
„Inhaltsangabe“ gehört möglicherweise zu einer anderen Auflage dieses Titels.
Über die Autorin bzw. den Autor
„Über diesen Titel“ gehört möglicherweise zu einer anderen Auflage dieses Titels.